| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/21/2009 | US20090130122 Methods for treating rheumatoid arthritis using IL-17 antagonists |
| 05/21/2009 | US20090130121 Synthetic Peptide Copolymers for Treatment and Prevention of Cardiovascular Disorders |
| 05/21/2009 | US20090130120 monoclonal antibodies and fragments that bind to conserved epitopes of the G protein of respiratory syncytial virus(RSV) and which are minimally immunogenic when administered to humans, useful in treating RSV infections |
| 05/21/2009 | US20090130119 Anti-ctla-4 antibody compositions |
| 05/21/2009 | US20090130118 Scutellaria barbata extract and combinations for the treatment of cancer |
| 05/21/2009 | US20090130117 Substituted Tetrazole Compounds and Uses Thereof |
| 05/21/2009 | US20090130116 Use of CEACAM8-Specific Substances for Treating Autoimmune Diseases and a Method for Screening Substances Which Induce Apoptosis |
| 05/21/2009 | US20090130115 Antibodies recognizing a highly expressed putative antigen of ca-mrsa and methods of use |
| 05/21/2009 | US20090130114 Wise binding agents and epitopes |
| 05/21/2009 | US20090130113 Compositions and methods for use for antibodies against sclerostin |
| 05/21/2009 | US20090130112 Spatial for altering cell proliferation |
| 05/21/2009 | US20090130111 Method of Identifying Membrane Ig Specific Antibodies and Use Thereof for Targeting Immunoglobulin-Producing Precursor Cells |
| 05/21/2009 | US20090130110 High affinity fully human monoclonal antibodies to interleukin-8 and epitopes for such antibodies |
| 05/21/2009 | US20090130109 DCL-1 and uses thereof |
| 05/21/2009 | US20090130108 N-Cadherin and Ly6 E: Targets for Cancer Diagnosis and Therapy |
| 05/21/2009 | US20090130107 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 05/21/2009 | US20090130106 Demibodies: dimerization-activated therapeutic agents |
| 05/21/2009 | US20090130105 Compositions that bind multiple epitopes of igf-1r |
| 05/21/2009 | US20090130104 Fusion proteins for inhibition and dissolution of coagulation |
| 05/21/2009 | US20090130103 Purification and protective efficacy of monodisperse and modified yersinia pestis capsular f1-v antigen fusion proteins for vaccination against plague |
| 05/21/2009 | US20090130102 Methods for humanizing antibodies and humanized antibodies made thereby |
| 05/21/2009 | US20090130101 Anti-cancer therapy with an extract of scutellaria barbata |
| 05/21/2009 | US20090130100 Methods of using humanized antibodies and compositions for binding sphingosine-1-phosphate |
| 05/21/2009 | US20090130099 Humanized antibodies and compositions for binding sphingosine-1-phosphate |
| 05/21/2009 | US20090130098 Specific therapy using integrin ligands for treating cancer |
| 05/21/2009 | US20090130097 Quinazolinone Compounds and Methods of Use Thereof |
| 05/21/2009 | US20090130096 Gene Signature of Early Hypoxia to Predict Patient Survival |
| 05/21/2009 | US20090130095 Composition comprising tumor necrosis factor (CD40) specific immunoglobulin for treatment and prevention of autoimmune diseases |
| 05/21/2009 | US20090130094 Cytotoxic Antibodies Directed Against Antibodies Inhibiting Factor VIII |
| 05/21/2009 | US20090130093 Binding member for gm-csf receptor |
| 05/21/2009 | US20090130092 Nucleotide phosphate dissipation as a treatment for vascular disorders |
| 05/21/2009 | US20090130091 Compounds for hedgehog pathway blockade in proliferative disorders, including hematopoietic malignancies |
| 05/21/2009 | US20090130090 N-amide Derivatives of 8-Azabicyclo[3.2.1]OCT-3-YL AS CCR1 Antagonists |
| 05/21/2009 | US20090130089 Anti-cd20 antibodies and methods of use |
| 05/21/2009 | US20090130088 Compositions and methods for regulating RNA translation via CD154 CA-dinucleotide repeat |
| 05/21/2009 | US20090130084 Tagged IgA1 proteases |
| 05/21/2009 | US20090130021 Methods, products and uses involving platelets and/or the vasculature |
| 05/20/2009 | EP2060918A2 Breast endothelial cell expression patterns |
| 05/20/2009 | EP2060634A1 Structure protein of adeno-associated virus with amended antigenity, production and application thereof |
| 05/20/2009 | EP2060631A2 Characterization of granulocytic ehrlichia and methods of use |
| 05/20/2009 | EP2060630A2 PCA3, PCA3 genes, and methods of use |
| 05/20/2009 | EP2060271A1 Liposome and immunostimulating composition comprising the same |
| 05/20/2009 | EP2060270A2 Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof |
| 05/20/2009 | EP2060269A2 Modulation of immunostimulatory properties by small oligonucleotide-based compounds |
| 05/20/2009 | EP2060252A1 New formulation of galactosylceramide derivatives |
| 05/20/2009 | EP2059807A1 Diagnosing pneumococcal pneumonia |
| 05/20/2009 | EP2059602A2 Methods and compositions for increasing tissue tropism of recombinant adenoviral vectors |
| 05/20/2009 | EP2059593A2 Treating or preventing cancers over-expressing reg4 or kiaa0101 |
| 05/20/2009 | EP2059534A1 Engineered anti-il-23p19 antibodies |
| 05/20/2009 | EP2059533A2 Multispecific antibodies |
| 05/20/2009 | EP2059262A1 A dna vaccine for treating or preventing cervical cancer comprising a gene encoding hpv protein |
| 05/20/2009 | EP2059258A2 Arginine wash in protein purification using affinity chromatography |
| 05/20/2009 | EP2059257A2 Use of glycolipids as adjuvants |
| 05/20/2009 | EP2059256A1 Immunogenic peptides and their use in immune disorders |
| 05/20/2009 | EP2059255A2 Hsv-1 and hsv-2 vaccines and methods of use thereof |
| 05/20/2009 | EP2059236A2 Combination with bis(thiohydrazide amides) for treating cancer |
| 05/20/2009 | EP1835922B1 Combination treatment for multiple sclerosis |
| 05/20/2009 | EP1789800B1 Ileitis diagnostic assay |
| 05/20/2009 | EP1592789B1 Administration of transposon-based vectors to reproductive organs |
| 05/20/2009 | EP1574521B1 Method of protecting of thiol groups in antibodies |
| 05/20/2009 | EP1401492B1 Ltb4 as vaccine adjuvant |
| 05/20/2009 | EP1331944B1 Use of cd28-specific monoclonal antibodies for stimulating blood cells that lack cd28 |
| 05/20/2009 | EP1231910B1 Pentamidine for treating cancer |
| 05/20/2009 | EP1223975B1 MUCOSAL DTPa VACCINES |
| 05/20/2009 | EP0651789B2 Method for preventing zoster and alleviating varicella related post-herpetic neuralgia |
| 05/20/2009 | CN101437956A Humanized anti-CD20 monoclonal antibody |
| 05/20/2009 | CN101437852A Anti-TAT226 antibodies and immunoconjugates |
| 05/20/2009 | CN101437851A Cancerous disease modifying antibodies for diagnostic and therapeutic use in breast and prostate cancer |
| 05/20/2009 | CN101437850A Anti-5T4 antibodies and uses thereof |
| 05/20/2009 | CN101437841A Virosome-like vesicles comprising gp41-derived antigens |
| 05/20/2009 | CN101437550A Real-time detection of influenza virus |
| 05/20/2009 | CN101437543A Combination comprising a VEGF inhibitor and a serine protease for treating neovascular diseases |
| 05/20/2009 | CN101437541A Methods of treating inflammatory and autoimmune diseases with natalizumab |
| 05/20/2009 | CN101437540A Melanocortin receptor binding mimetibodies, compositions, methods and uses |
| 05/20/2009 | CN101437539A Blocking leukocyte emigration and inflammation by interfering with CD99L2 |
| 05/20/2009 | CN101437538A Modified adenovirus hexon protein and uses thereof |
| 05/20/2009 | CN101437537A Cancer vaccine |
| 05/20/2009 | CN101437536A Anti-tumor cell antigen antibody therapeutics |
| 05/20/2009 | CN101437501A Prolongation of survival of an allograft by inhibiting complement activity |
| 05/20/2009 | CN101434956A Heavy and light chain variable region gene of monoclonal antibody, encoding polypeptide thereof and use |
| 05/20/2009 | CN101434951A Method for obtaining wire-worm microsome amino peptidase gene and use thereof |
| 05/20/2009 | CN101434928A Recombinant bacteria expressing avian Escherichia coli type 1 pilin, and construction method and use thereof |
| 05/20/2009 | CN101434654A Neutralizing antibody against HGF and neutralizing antibody binding to the same |
| 05/20/2009 | CN101434647A Epitope/peptide recognized by hla-a2402-restricted ep/cam-specific ctl and use of the same |
| 05/20/2009 | CN101433715A Modified chimeric polypeptides with improved pharmacokinetic properties |
| 05/20/2009 | CN101433657A Toxin-expelling anticancer Chinese medicament preparation |
| 05/20/2009 | CN100489107C DNA transfection system for the generation of infectious influenza virus |
| 05/20/2009 | CN100489105C Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector |
| 05/20/2009 | CN100489094C Proteins with altered immunogenicity and methods of making and using the same |
| 05/20/2009 | CN100489092C Type II genetic marker strain of porcine circovirus and its application |
| 05/20/2009 | CN100488984C Reducing immunogenicity of fusion proteins |
| 05/20/2009 | CN100488981C Proaerolysin containing protease activation sequences and its uses |
| 05/20/2009 | CN100488563C Modified anti-EGFR antibody with reduced immunogenicity |
| 05/19/2009 | US7534877 Non-M, non-O HIV-1 strains, fragments and uses |
| 05/19/2009 | US7534869 Small and intermediate conductance, calcium-activated potassium channels and uses thereof |
| 05/19/2009 | US7534857 Methods and compositions for the treatment and prevention of staphylococcal infections |
| 05/19/2009 | US7534772 Methods for enhancing antibody-induced cell lysis and treating cancer |
| 05/19/2009 | US7534605 CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases |
| 05/19/2009 | US7534596 Method and device for producing vaccine |
| 05/19/2009 | US7534559 Feline polynucleotide vaccine formula |